Angioedema Treatment Market Global Trends, Market Share, Company Size, Growth, Opportunities and Market Forecast - 2021 to 2028

Angioedema Treatment Market 

Angioedema is a medical condition characterized by the swelling of subcutaneous or submucosal tissues, which typically affects the face, lips, tongue, throat, and/or genitals. This condition can be hereditary or acquired and can occur as an allergic or non-allergic reaction. The treatment of angioedema aims to reduce the swelling and prevent recurrent episodes.

The Angioedema Treatment Market is growing due to the increasing prevalence of this condition, which is estimated to affect up to 20% of the population at some point in their lives. In addition, the rising demand for effective and safe treatment options is expected to drive market growth.

There are several types of angioedema, including hereditary angioedema (HAE), acquired angioedema (AAE), and idiopathic angioedema. HAE is a rare genetic disorder caused by a deficiency of C1 inhibitor, a protein that regulates the complement and kinin pathways. AAE, on the other hand, is typically caused by an autoimmune disorder or as a side effect of medication. Idiopathic angioedema is a form of angioedema where the underlying cause is unknown.

The expansion of the global Angioedema Treatment Market is anticipated to be boosted by regulatory authorities often approving innovative medications.

The treatment of angioedema varies depending on the type of angioedema and the severity of the symptoms. For acute angioedema, treatment typically involves the use of antihistamines, corticosteroids, and/or epinephrine. In more severe cases, patients may require hospitalization and intravenous administration of medications, such as C1 inhibitor concentrate, ecallantide, or icatibant.

There are several drugs available in the Angioedema Treatment Market, including antihistamines, corticosteroids, C1 inhibitor concentrate, ecallantide, and icatibant. Antihistamines are commonly used for the treatment of mild to moderate allergic reactions and are also effective for the treatment of mild to moderate angioedema. Corticosteroids are anti-inflammatory drugs that can be used to reduce swelling and inflammation associated with angioedema.

Throughout the projected period, prominent market players' use of inorganic tactics including partnerships, collaborations, and others is anticipated to propel the expansion of the worldwide Hemophilia Treatment Market.

C1 inhibitor concentrate is a protein replacement therapy that can be used for the treatment of hereditary angioedema. This therapy works by replacing the deficient C1 inhibitor protein and inhibiting the complement and kinin pathways that are responsible for the swelling and inflammation associated with angioedema. Ecallantide and icatibant are medications that can be used for the treatment of acute attacks of hereditary angioedema. These drugs work by inhibiting the activity of bradykinin, a peptide that is involved in the pathogenesis of angioedema.